stock details $1.97B […] Roche Annual General Meeting 2021 Contacts for Private Investors; Investor Contacts in Europe; Investor Contacts in North America; Stay Up-to-Date. GlaxoSmithKline plc 980 Great West Road Brentford Middlesex TW8 9GS. Amazon Investor Relations Investor Presentation. GSK Nigeria Investors Financial Calendar. Sept 2020 Tel: pref +44 (0)20 8047 5000. Sep 30, 2020. Communication with the Investment Community - Spokespersons The Investor Relations function is responsible for GSK’s dissemination of information to financial analysts and institutions. Investor Relations PRESS RELEASES Mar 02, 2021 Epizyme Outlines Clinical Progress, TAZVERIK Development Strategy and Pipeline Priorities During Company’s Strategic Vision Call Feb 24, 2021 Epizyme to Host Strategic Vision Call on March 2, 2021. Explore our Investors section on aviva.com. Brand Portfolio. In the last reported quarter, the company delivered earnings surprise of 17.95%. Posted Financial Results for 2Q/FY2020. The Latest News March 4, 2021 Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina . March 2021. Modern Slavery Statement 2020. For investor inquiries related to the Nightstar Therapeutics acquisition, please contact Biogen Investor Relations at IR@biogen.com. Investor Relations Contacts. Sharing our research We are committed to reporting the results of clinical research that evaluates product efficacy, irrespective of whether the outcomes are perceived to be positive or negative. GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business. 12:13 pm. GSK Consumer Healthcare is a great place to work, being an equal opportunity provider we believe in offering job opportunities to deserving talent. Innoviva, Inc. is a company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited (“GSK”), including RELVAR®/BREO® ELLIPTA® (fluticasone furoate/ vilanterol, “FF/VI”), ANORO® ELLIPTA® (umeclidinium bromide/ vilanterol, “UMEC/VI”) and TRELEGY® ELLIPTA® (the combination FF/UMEC/VI). Update on merger of GSK CH with HUL: April 2020; GSK CH Merger Update : July 2020. Stay connected to the latest news and information from Novartis. Please contact our GSK Response Center on Toll Free +1 888 825 5249. 1:25 pm. Annual Report 2013 by sections. Key Announcements. Registrar. Investor Relations. Director of US Investor Relations GSK Jul 2018 - Present 2 years 8 months. We are committed to reporting the results of clinical research that evaluate our medicines and vaccines, irrespective of whether the outcomes are perceived to be positive or negative. INVESTOR CONTACTS. 2020 Full Year Results Presentation (PDF). The Investor Relations website contains information about Moderna, Inc.'s business for stockholders, potential investors, and financial analysts. For questions about investor relations or the share registry, please contact our team. GSK Registrar Contact Registrar. The Investor Relations website contains information about Carnival Corporation & plc's business for stockholders, potential investors, and financial analysts. Published on: 16 March 2021. Imperial Brands Science. Published on: 17 March 2021. MDM Professionals. Latest News and Presentations. GSK is one of the world's foremost pharmaceutical and healthcare companies and we are proud to be leading a … Read more. Our vision is to making lives better by bringing “Quality, Affordable Self-Care Products” that consumers trust everywhere they are sold.The Company is a leading provider of health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Souheil Salah Investor Relations Operations Director at GSK Brentford, Greater London, United Kingdom 500+ connections London, England, United Kingdom Founder Clear Giraffe IR Nov 2017 - Jul 2020 2 years 9 months. Stock Quotes (TSE 1st:4503) View Stock Performance. View contact details for investors, analysts and individual shareholders. Roche launches cobas pure integrated solutions analyser to help simplify operations in small to medium sized labs more. IR News. Investor Relations We create stockholder value through high-margin brands and a disciplined acquisition strategy, and by returning a meaningful portion of our excess cash to our stockholders. Netflix Investor Relations Investor Presentation. Latest Stock Picks Investing Basics ... Head of Investor Relations, who will introduce today's session. Sustainability. Investor Relations UK. Fax: fax +44 (0)20 8047 7807. Oct 30, 2020. Equiniti Limited Aspect House Spencer Road Lancing West Sussex BN99 6DA Tel: … We create stockholder value through high-margin brands and a disciplined acquisition strategy, and by returning a meaningful portion of our excess cash to our stockholders. Follow Us . Annual Report 2020. Experienced Professionals USEFUL LINKS. These pages provide information and data taken from the GlaxoSmithKline plc (GSK… Our sustainability strategy is aligned to the principles of the Global Compact and seeks to advance the broader Sustainable Development Goals of … Consumer Healthcare Head of Investor Relations GSK Jul 2020 - Present 9 months. Investor Relations IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. GSK Investor Relations UK Contact Investor Relations UK. Other than the Chairman, CEO and Chief Financial Officer, and Investor Relations management, no – Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death – – Vir and GSK plan to immediately seek Emergency Use Authorization in the U.S. and authorizations in other countries – – Additional new in vitro studies indicate VIR-7831 maintains activity against major circulating COVID-19 variants – GlaxoSmithKline plc GSK will report fourth-quarter 2020 results on Feb 3, before market open. Perrigo is a leading global consumer-focused self-care company. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. In this section you can find out what life at GSK is really like. Investor updates All. We use cookies to collect and analyse information on our site's performance and to enable the site to function. GSK aspires to be one of the world’s most innovative, best performing and trusted healthcare companies and Data is changing the way we think and work at GSK. These documents are available from the Securities and Exchange Commission, the Bristol Myers Squibb website or from Bristol Myers Squibb Investor Relations. Annual Report 2020 is now available. 2020 Full Year Results CEO Script (PDF). Wood is a member of the United Nations Global Compact. Download [929.52 KB] GlaxoSmithKline. Our Locations. GSK Investor Relations Investor Presentation . Updated “R&D Meeting” Section. Sally Ferguson has taken over as global head of IR at pharmaceutical company GlaxoSmithKline ().She replaces David Mawdsley, GSK’s head of IR since 2007, who has been promoted to the role of vice president of global media relations. Our headquarter is in London and we employ over 99,000 people in 115 countries. Working at GSK. … Investor Relations Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Jan 29, 2021. Results Centre. In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. Recent news 1:37 am. GSK CH Merger Update : July 2020 A teleconference / webcast was hosted by Mr. Srinivas Phatak – Chief Financial Officer on 22nd July, 2020 at 16:00 hours. GSK earnings call for the period ending June 30, 2020. Month Average Price High Price Low Price; September 2002: 339.33: 367.00: 314.00: October 2002 Investor Relations 4.1.1. ... Google alphabet Investor Relations Investor Presentation. Posted Financial Results for 3Q/FY2020. 2020 Full Year Results Announcement. Dec 10, 2020. 8:53 am. Sharing our research. Aug 04, 2020.